(19)
(11) EP 2 661 448 A2

(12)

(88) Date of publication A3:
30.08.2012

(43) Date of publication:
13.11.2013 Bulletin 2013/46

(21) Application number: 12732270.9

(22) Date of filing: 06.01.2012
(51) International Patent Classification (IPC): 
C07K 16/24(2006.01)
A61K 39/395(2006.01)
(86) International application number:
PCT/US2012/020529
(87) International publication number:
WO 2012/094623 (12.07.2012 Gazette 2012/28)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 07.01.2011 US 201161460780 P

(71) Applicant: AbbVie Inc.
North Chicago, IL 60064 (US)

(72) Inventors:
  • BORHANI, David, W.
    Hartsdale, NY 10530 (US)
  • SADHUKHAN, Ramkrishna
    Acton, MA 01720 (US)
  • LACY, Susan, E.
    Westborough, MA 01581 (US)
  • SOUTTER, Holly, H.
    Shrewsbury, MA 01545 (US)

(74) Representative: Modiano, Micaela Nadia et al
Modiano & Partners (DE) Thierschstrasse 11
80538 München
80538 München (DE)

   


(54) ANTI-IL-12/IL-23 ANTIBODIES AND USES THEREOF